Estados Unidos · Plataformas y datos · Finviz

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

Publicado por Finviz · Estados Unidos hace 21 h

Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous…

Leer el artículo completo en Finviz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finviz.com)

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

También te puede interesar

AI Regulation Was on the Ballot In These States. Here Are The Elon Musk Stocks That Could Be Impacted.

IREN Q1 earnings on deck: what to expect

Depressing, but true: If you want to get ahead at work, embrace virtue signaling

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Gulfport Energy earnings up next: Data centers vs. weak gas prices

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

Compartir

También te puede interesar

AI Regulation Was on the Ballot In These States. Here Are The Elon Musk Stocks That Could Be Impacted.

IREN Q1 earnings on deck: what to expect

Depressing, but true: If you want to get ahead at work, embrace virtue signaling

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Gulfport Energy earnings up next: Data centers vs. weak gas prices